Teleflex Medical OEM

Teleflex Medical OEM, based in the US, specializes in the co-development and manufacture of innovative medical devices tailored to meet critical healthcare needs across various medical sectors. Founded in the US, Teleflex Medical OEM operates in the medical device industry by offering customized solutions in collaboration with healthcare providers and manufacturers. The company was acquired in December 2025 for USD 1. 5 billion by Montagu Private Equity and Kohlberg & Company, allowing it to expand its customer base and geographic reach.

The deal is subject to regulatory approvals and customary closing conditions and is expected to be completed in the second half of 2026. As part of the transaction, Greg Stotts will assume the role of CEO. Teleflex Medical OEM specializes in the co-development and manufacture of medical devices tailored to meet the needs of industry leaders. Their core product offerings include a range of advanced medical technologies designed for various applications, particularly in critical care, surgical, urology, and respiratory markets.

The firm focuses on improving device design and functionality to enhance patient outcomes, ensuring that their solutions address critical healthcare challenges. Teleflex Medical OEM serves a global client base, including hospitals, healthcare providers, and medical device manufacturers across North America, Europe, and Asia-Pacific regions. Their commitment to quality and innovation is evident in partnerships with leading companies, enabling the development of customized solutions that adhere to stringent regulatory standards. Teleflex Medical OEM generates revenue primarily through direct partnerships with healthcare institutions and medical device manufacturers, leveraging a business-to-business (B2B) model.

Transactions are structured around co-development agreements and product sales, where clients may engage in long-term contracts to source specific medical device solutions. Revenue streams are further supplemented by sales of their flagship products, such as those associated with their EPIC Medtec and Force Fiber Fusion brands. Each transaction typically involves customized pricing plans based on the scale and specifications of the devices ordered, allowing for flexibility in meeting client demands while ensuring quality and compliance. This structured approach supports stable revenue generation, fostering long-lasting relationships with their client base in the medical sector.

Following the acquisition in December 2025, Teleflex Medical OEM plans to leverage its new ownership to expand its product offerings and target new markets. The company aims to broaden its geographic footprint, particularly focusing on emerging markets in Asia-Pacific and Europe by 2026. The acquisition funding of USD 1. 5 billion will help support these growth initiatives, enabling the development of new products and enhancing their operational capabilities.